If you take medication to treat high blood pressure, you may want to check your cabinets.
Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets due to the detection of trace amounts of an unexpected impurity (NDEA), according to the FDA.
N-nitrosodiethylamine, or NDEA, has been classified as a probable human carcinogen, meaning it could cause cancer.
Here is the affected product:
33342-0052-10Macleods Pharmaceuticals LimitedLosartan Potassium/ Hydrochlorothiazide combination tablets 100mg/25mg, 90 count bottlesBLM715AJul -2019
Do not stop taking the medication without consulting your doctor, and tell your doctor if you have had any problems while taking the medication.
You can contact recall@qualanex.com or call 888-280-2042 with any questions.
You can read the full report here.